Full Course Description

Psychedelic-Assisted Psychotherapy for Complex Trauma: Core Principals and Clinical Applications for the Future of Trauma Treatment

This program, Psychedelic Assisted Therapy, describes the psychedelic medications being researched and utilized to enhance clinical outcomes in the context of Psychedelic Assisted Psychotherapy. Through a combination of research findings and interviews with providers familiar with these medications, this program seeks to inform, explain, and evaluate the role of psychedelic medicine and Psychedelic Assisted Psychotherapy for clinical practice and efficacy. The medications will be categorized and analyzed. Considerations for clinical application will be discussed. This program will assess the benefits, harm, and limits of using psychedelics. Research and current application will be investigated. Training, the role of the therapist, and long terms impacts will be discussed.

Program Information

Objectives

Determine the clinical experiences of experts working with psychedelics.
Defend psychedelics as an effective clinical intervention, not just a drug.
Investigate the role of the clinician in Psychedelic Assisted Therapy.
Evaluate the practice of centering of the client in treatment and demonstrate client’s innate ability to heal themselves.
Identify the risks of Psychedelic Assisted Therapy and of the individual psychedelics.
Determine the legal status and scheduling of psychedelics.
Evaluate the clinical implications of underground therapists and assess the need for clinical guidelines and oversight.
Propose considerations for clinical training beyond medication training, including trauma informed training, psychedelic training, Polyvagal Theory, Acceptance and Commitment Therapy, and Internal Family Systems and evaluate the significance of the clinician’s personal experience with psychedelics and trauma growth.
Demonstrate the effectiveness of Psilocybin treatment via a comprehensive look into the Psilocybin trails for depression at the Imperial College in London.
Appraise the role and significance of touch in psychedelic experiences as a form of grounding and connection.
Appraise the role and significance of music in psychedelic experiences as a form of enhancement to the medication.
Argue the importance of psychedelic medications and Psychedelic Assisted Therapy in community settings and as it relates to inclusion of marginalized people.

Outline

Introduction
Five Common Threads of Interviews
Introduction to the Interviewees
Order of Discussion & the Psychedelic Drugs Covered in this Presentation

Part 1: MDMA & MDMA Assisted Psychotherapy
MDMA Therapy Training

Interview with Michael Mithoefer, MD
Interview with Victor Cabral, LSW, CCTP-I
Interview with Jim Hopper, PhD
Interview with Rosalind Watts, PhD
Interview with Hannah McLane, MD, MA, MPH

History & Pharmacology of MDMA

Holographic Breathwork
- Interview with Michael Mithoefer, MD
- Interview with Stacia Butterfield
- Interview with Jim Hopper, PhD
- Interview with Bessel van der Kolk, MD

Drugscience.org.uk MDMA Information

What is MDMA
Scheduling of Drugs (www.dea.gov)
Drug Classes
- Stimulants
- Hallucinogens
- Dissociative Anesthetics
Risks of MDMA
MDMA Pharmacology
Psychoactive Properties
Physiological Effects
Psychological Effects
Therapeutic Applications
Treatment Process & Steps

MDMA Treatment Process/Steps

ACES & Childhood Trauma: Interview with Deran Young, LCSW
Trauma-Informed Care: Interview with Victor Cabral, LSW, CCTP-I
MDMA Outcomes: Interview with Michael Mithoefer, MD
Internal Family Systems Therapy: Interviews with Richard Schwartz, PhD; Bessel van der Kolk MD; Deran Young, LCSW
MDMA Therapy Training: Set & Setting: Interview with Jennifer Baldwin, PhD
Music in Psychedelic Assisted Therapy: Interview with Mendel Kaelen, PhD
Significance of Trauma: Interview with Leslie Korn, PhD, MPH
Preparation, Medicine, Integration: Interview with Jennifer Baldwin, PhD & Jim Hopper PhD

Conclusion of Part 1

Resources

Part 2: Psilocybin & Psilocybin Assisted Therapy Training
Working & Training with Psychedelics

How to Start Working with Medicines: Interview with Jennifer Baldwin, PhD
Training to do Medication Work, Good Trauma Treatment, & Psychedelic Treatment in Trauma Informed Therapy: Interview with Jim Hopper, PhD
Training with Medications: Michael Mithoefer, MD

Other Drugs: Interview with Jennifer Baldwin PhD

Introduction to Ketamine
Psychedelic Cannabis
MDMA
Classic Psychedelics

Drugscience.org.uk Psilocybin Information

What is Psilocybin
Psilocybin History
Potential Harm
Psilocybin Pharmacology
Therapeutic Applications, Mechanisms, & Practicalities
Preparatory Psychotherapy
Active Psilocybin Sessions
Integrative Psychotherapy
Why We Need More Research

Interview with Rosalind Watts, PhD

Psilocybin Trails for Depression at the Imperial College in London, Visualization, Treatment Preparation, Integration, & Psychological Flexibility
Guided Imagery: Interview with Belleruth Naparstek
Challenges with Schedules for Treatment: Interview with Michael Mithoefer, MD
Acceptance & Commitment Therapy, Being Grounded in the Body, Trauma & Addiction: Interview with Jim Hopper, PhD

The Polyvagal Theory

Interview with Stephen Porges, PhD
Interview with Bessel van der Kolk, MD
Interview with Rosalind Watts, PhD

Underground Therapists & Clinical Implications

Interview with Michael Mithoefer, MD
Interview with Jim Hopper, PhD
Interview with Bessel van der Kolk, MD

Touch in Clinical Work

Harry Harlow Monkey Studies
Brain Development: Interview with Linda Curran
Permission to Touch: Interview with Michael Mitheofer, MD
Therapist Accountability: Interview with Jim Hopper, PhD
Accountability & Safety: Interview with Rosalind Watts, PhD
Medication Treatment Guidelines & Psychedelic Training: Interview with Bessel van der Kolk, MD
Medication Treatment Guidelines: Interview with Mendel Kaelen, PhD
Harm Reduction: Interview with Jennifer Baldwin, PhD

Conclusion of Part 2

Resources

Part 3: Ketamine & Ketamine Assisted Psychotherapy
Experiences with Ketamine & Creating Safety: Interview with Bessel van der Kolk, MD
Facilitating Experiences: Interview with Mendel Kaelen, PhD
Interview with Jennifer Baldwin, PhD

MDMA Assisted Group Therapy
Set & Setting
What is the Wound? What is the Practice? What is the Medicine?
Circular Conscious Breathing

Interview with Staci Butterfield

Somatic Awareness
Plant Medicine & Holotropic Breathwork
Stan Grof: The Healing Potential of Non-Ordinary States of Consciousness Video Clips
Grof Cartography of the Psyche
Exploration of Breath
Breathwork Training
Music for Holotropic Breathwork: Interview with Mendel Kaelen, PhD
Contraindications to Holotropic Breathwork

Interview with Bessel van der Kolk, MD

Clinical Experiences Working with Patients Using Ketamine & MDMA
Positive & Negative Impacts of MDMA & Ketamine
How to Introduce Ketamine to Clients

Interview with Leslie Korn, PhD, MPH

Complex Trauma & the Importance of Creating Safety
Dissociative Drugs

Interview with Jim Hopper, PhD

Preparation for Ketamine Assisted Therapy
Clinical Experiences Using Ketamine

Drugscience.org.uk Ketamine Information

What is Ketamine?
Recreational Use & Mental Health Use
Ketamine Research
Ketamine Pharmacology
Ketamine Assisted Psychotherapy & Off-Label Ketamine Treatment

Ketamine in Clinical Context: Interview with Jennifer Baldwin, PhD
The Differential Effects of Psychedelic Drugs: Interview with Bessel van der Kolk, MD
Being a Medical Doctor Providing Ketamine: Interview with Michael Mitheofer, MD
Internal Family Systems & Ketamine: Interviews with Deran Young, LCSW & Jennifer Baldwin, PhD
Interview with Victor Cabral, LSW, CCTP-I

Policy in the Psychedelic State
Post Graduate Certificate in Ketamine Assisted Therapy
Personal Experiences with Ketamine
Internal Family Systems & Ketamine and Communal Healing

Hannah McLane, MD, MA, MPH

Ketamine Assisted Psychotherapy with Psychoanalysis
Psilocybin Facilitators Trainings
Psychedelic Legalization

Benefits, Intention, & Processing of Psychedelics: Interviews with Jim Hopper, PhD & Michael Mithoefer, MD
Interview with Hannah McLane, MD, MA, MPH

Inner Healing
Intelligence
Neuroplasticity

Holding the Space for Clients in a Psychedelic State: Interview with Jim Hopper, PhD
Psychedelic Training Programs & Resources: Interview with Michael Mithoefer, MD
Interview with Deran Young, LCSW

Internal Family Systems
Collective Resonance of Parts
Creating Emotional and Psychological Safety at Work for Marginalized People
Inclusivity & Equity

Interview with Victor Cabral, LSW, CCTP-I

Making Polices & Regulations for Psychedelics
Documentary: “Transcendence” Trailer

Conclusion of Part 3 & Psychedelic Assisted Therapy Program

Resources & Training Recommendations
Contributor Bios

Target Audience

Counselors
Psychotherapists
Social Workers
Addiction Counselors
Marriage and Family Therapists
Psychologists
Psychiatrists
Other Mental Health and Medical Providers